Gilead Sciences buying Immunomedics in $21 billion deal
Shares of the cancer drug specialist Immunomedics have more than doubled before the opening bell, a day after its sale t...
Shares of the cancer drug specialist Immunomedics have more than doubled before the opening bell, a day after its sale t...
The maker of a drug shown to shorten recovery time for severely ill COVID-19 patients says it will charge $2,340 for a t...
A California biotech company says its experimental drug remdesivir improved symptoms when given for five days to moderat...
The first results are in for an experimental antiviral drug against the new coronavirus
There is a smattering of green amid all that red on Wall Street